RE:RE:class warProbably because the bigger companies are not offering what PMN wants, yet. Nobody bought out Acumen yet either, and look at their market cap- $240M USD.
PMN's market cap is only $45M USD right now... so we are looking at a potential 6-bagger even if we just get to where Acumen is currently, which is not too far ahead of us... maybe 1 year.
The Boston group is providing the necessary capital to get to PhI. After we get great results with the biomarker and safety data, then the leverage in negotiations goes up immensely.
It has been a long haul in getting to PhI, certainly, but I'm holding through PhI. If we spike to acumen levels at the PhI start, I'll get my original investment out and ride the remaining 85% or so zero risk freebee shares into the sunset.
Cheers.